TY - JOUR
T1 - PUFA ω-3 and ω-6 biomarkers and sleep: a pooled analysis of cohort studies on behalf of the Fatty Acids and Outcomes Research Consortium (FORCE)
AU - Murphy, Rachel A.
AU - Tintle, Nathan
AU - Harris, William S.
AU - Darvishian, Maryam
AU - Marklund, Matti
AU - Virtanen, Jyrki K.
AU - Hantunen, Sari
AU - de Mello, Vanessa D.
AU - Tuomilehto, Jaakko
AU - Lindström, Jaana
AU - Bolt, Matthew A.
AU - Brouwer, Ingeborg A.
AU - Wood, Alexis C.
AU - Senn, Mackenzie
AU - Redline, Susan
AU - Tsai, Michael Y.
AU - Gudnason, Vilmundur
AU - Eiriksdottir, Gudny
AU - Lindberg, Eva
AU - Shadyab, Aladdin H.
AU - Liu, Buyun
AU - Carnethon, Mercedes
AU - Uusitupa, Matti
AU - Djousse, Luc
AU - Risérus, Ulf
AU - Lind, Lars
AU - van Dam, Rob M.
AU - Koh, Woon Puay
AU - Shi, Peilin
AU - Siscovick, David
AU - Lemaitre, Rozenn N.
AU - Mozaffarian, Dariush
N1 - Publisher Copyright:
© The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition.
PY - 2022/3
Y1 - 2022/3
N2 - BACKGROUND: n-3 and n-6 PUFAs have physiologic roles in sleep processes, but little is known regarding circulating n-3 and n-6 PUFA and sleep parameters. OBJECTIVES: We sought to assess associations between biomarkers of n-3 and n-6 PUFA intake with self-reported sleep duration and difficulty falling sleeping in the Fatty Acids and Outcome Research Consortium. METHODS: Harmonized, de novo, individual-level analyses were performed and pooled across 12 cohorts. Participants were 35-96 y old and from 5 nations. Circulating measures included α-linolenic acid (ALA), EPA, docosapentaenoic acid (DPA), DHA, EPA + DPA + DHA, linoleic acid, and arachidonic acid. Sleep duration (10 cohorts, n = 18,791) was categorized as short (≤6 h), 7-8 h (reference), or long (≥9 h). Difficulty falling asleep (8 cohorts, n = 12,500) was categorized as yes or no. Associations between PUFAs, sleep duration, and difficulty falling sleeping were assessed by cross-sectional multinomial logistic regression using standardized protocols and covariates. Cohort-specific multivariable-adjusted ORs per quintile of PUFAs were pooled with inverse-variance weighted meta-analysis. RESULTS: In pooled analysis adjusted for sociodemographic characteristics and health status, participants with higher very long-chain n-3 PUFAs were less likely to have long sleep duration. In the top compared with the bottom quintiles, the multivariable-adjusted ORs (95% CIs) for long sleep were 0.78 (95% CI: 0.65, 0.95) for DHA and 0.76 (95% CI: 0.63, 0.93) for EPA + DPA + DHA. Significant associations for ALA and n-6 PUFA with short sleep duration or difficulty falling sleeping were not identified. CONCLUSIONS: Participants with higher concentrations of very long-chain n-3 PUFAs were less likely to have long sleep duration. While objective biomarkers reduce recall bias and misclassification, the cross-sectional design limits assessment of the temporal nature of this relation. These novel findings across 12 cohorts highlight the need for experimental and biological assessments of very long-chain n-3 PUFAs and sleep duration.
AB - BACKGROUND: n-3 and n-6 PUFAs have physiologic roles in sleep processes, but little is known regarding circulating n-3 and n-6 PUFA and sleep parameters. OBJECTIVES: We sought to assess associations between biomarkers of n-3 and n-6 PUFA intake with self-reported sleep duration and difficulty falling sleeping in the Fatty Acids and Outcome Research Consortium. METHODS: Harmonized, de novo, individual-level analyses were performed and pooled across 12 cohorts. Participants were 35-96 y old and from 5 nations. Circulating measures included α-linolenic acid (ALA), EPA, docosapentaenoic acid (DPA), DHA, EPA + DPA + DHA, linoleic acid, and arachidonic acid. Sleep duration (10 cohorts, n = 18,791) was categorized as short (≤6 h), 7-8 h (reference), or long (≥9 h). Difficulty falling asleep (8 cohorts, n = 12,500) was categorized as yes or no. Associations between PUFAs, sleep duration, and difficulty falling sleeping were assessed by cross-sectional multinomial logistic regression using standardized protocols and covariates. Cohort-specific multivariable-adjusted ORs per quintile of PUFAs were pooled with inverse-variance weighted meta-analysis. RESULTS: In pooled analysis adjusted for sociodemographic characteristics and health status, participants with higher very long-chain n-3 PUFAs were less likely to have long sleep duration. In the top compared with the bottom quintiles, the multivariable-adjusted ORs (95% CIs) for long sleep were 0.78 (95% CI: 0.65, 0.95) for DHA and 0.76 (95% CI: 0.63, 0.93) for EPA + DPA + DHA. Significant associations for ALA and n-6 PUFA with short sleep duration or difficulty falling sleeping were not identified. CONCLUSIONS: Participants with higher concentrations of very long-chain n-3 PUFAs were less likely to have long sleep duration. While objective biomarkers reduce recall bias and misclassification, the cross-sectional design limits assessment of the temporal nature of this relation. These novel findings across 12 cohorts highlight the need for experimental and biological assessments of very long-chain n-3 PUFAs and sleep duration.
KW - biomarkers
KW - diet
KW - fatty acids
KW - omega-3
KW - public health
KW - sleep quality
UR - http://www.scopus.com/inward/record.url?scp=85125683134&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125683134&partnerID=8YFLogxK
U2 - 10.1093/ajcn/nqab408
DO - 10.1093/ajcn/nqab408
M3 - Article
C2 - 34918026
AN - SCOPUS:85125683134
SN - 0002-9165
VL - 115
SP - 864
EP - 876
JO - The American Journal of Clinical Nutrition
JF - The American Journal of Clinical Nutrition
IS - 3
ER -